Deutsch English Français

Contact

EP3600402

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP3600402

EP3600402 - SELF-ASSEMBLING PROTEIN NANOPARTICLES WITH BUILT-IN SIX-HELIX BUNDLE PROTEINS [Right-click to bookmark this link]
Status	Examination is in progress Status updated on 03.02.2023 Database last updated on 18.10.2024
Former	Request for examination was made Status updated on 03.01.2020
Former	The international publication has been made Status updated on 29.09.2018
Former	unknown Status updated on 19.04.2018
Most recent event Tooltip	28.03.2024	New entry: Renewal fee paid
Applicant(s)	For all designated states Alpha-O Peptides AG Lörracherstrasse 50 4125 Riehen / CH
	[2020/06]
Inventor(s)	01 / KULANGARA, Caroline Schwarzwaldallee 171 4058 Basel / CH
	02 / PAULILLO, Sara Maria Oltingerstrasse 53 4055 Basel / CH
	03 / PIAZZA, Matteo 106 Faulkner Street Chester CH2 3BQ / GB
	04 / RAMAN, Senthil Kumar Neuensteinerstrasse 27 4053 Basel / CH
	05 / BURKHARD, Peter An der Halden 18 79650 Schopfheim / DE
	[2020/06]
Representative(s)	Latscha Schöllhorn Partner AG Grellingerstrasse 60 4052 Basel / CH
	[2020/06]
Application number, filing date	18715541.1	22.03.2018
	[2020/06]
	WO2018EP57264
Priority number, date	EP20170162540	23.03.2017 Original published format: EP 17162540
	[2020/06]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2018172447
	Date:	27.09.2018
	Language:	EN
	[2018/39]
	Type:	A1 Application with search report
	No.:	EP3600402
	Date:	05.02.2020
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 27.09.2018 takes the place of the publication of the European patent application.
	[2020/06]
Search report(s)	International search report - published on:	EP	27.09.2018
Classification	IPC:	A61K39/12, C07K14/005	[2020/06]
	CPC:	A61K39/12 (EP,EA); C07K14/005 (EP,EA,US); A61K39/145 (EA,US); A61K39/21 (EA,US); A61K2039/55555 (EP,EA,US); C07K2319/73 (EP,EA,US); (+) C07K2319/735 (EP,EA,US); C12N2710/16034 (EP,EA,US); C12N2740/16134 (EP,EA,US); C12N2760/16134 (EP,EA,US) (-)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/06]
Title	German:	SELBSTANORDNENDE PROTEINNANOPARTIKEL MIT EINGEBAUTEN SECHS-HELIX-BÜNDELPROTEINEN	[2020/06]
	English:	SELF-ASSEMBLING PROTEIN NANOPARTICLES WITH BUILT-IN SIX-HELIX BUNDLE PROTEINS	[2020/06]
	French:	NANOPARTICULES DE PROTÉINE À AUTO-ASSEMBLAGE AVEC DES PROTÉINES À FAISCEAU DE SIX HÉLICES INTÉGRÉES	[2020/06]
Entry into regional phase	17.10.2019	National basic fee paid
	17.10.2019	Designation fee(s) paid
	17.10.2019	Examination fee paid
Examination procedure	17.10.2019	Examination requested [2020/06]
	17.10.2019	Date on which the examining division has become responsible
	07.05.2020	Amendment by applicant (claims and/or description)
	03.02.2023	Despatch of a communication from the examining division (Time limit: M06)
	05.09.2023	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
	30.10.2023	Reply to a communication from the examining division
Request for further processing for:	The application is deemed to be withdrawn due to failure to reply to the examination report
	30.10.2023	Request for further processing filed
	30.10.2023	Full payment received (date of receipt of payment) Request granted
	08.11.2023	Decision despatched
Fees paid	Renewal fee
	17.10.2019	Renewal fee patent year 03
	24.03.2021	Renewal fee patent year 04
	25.03.2022	Renewal fee patent year 05
	23.03.2023	Renewal fee patent year 06
	27.03.2024	Renewal fee patent year 07
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[AD]WO2013044203 (US HEALTH [US]) [AD] 1-15 * page 82, line 14 - page 83, line 12 * * figure 18 *;
		[AD]WO2014079842 (NOVARTIS AG [CH], et al) [AD] 1-15 * page 7, line 25 - page 8, line 6 * * figure 3 * * page 19, line 32 - page 20, line 17 *;
		[AD]WO2015104352 (ALPHA O PEPTIDES AG [CH]) [AD] 1-15* the whole document *;
		[XDI] - PIMENTEL T A P F ET AL, "Peptide Nanoparticles as Novel Immunogens: Design and Analysis of a Protective Severe Acute Respiratory Syndrome Vaccine", CHEMICAL BIOLOGY & DRUG DESIGN, BLACKWELL PUBLISHING TD., OXFORD, GB, (20081218), vol. 73, no. 1, doi:10.1111/J.1747-0285.2008.00746.X, ISSN 1747-0277, pages 53 - 61, XP002540716 [XD] 1-4,13-15 * abstract * * figures 1,2 * [I] 5-11 DOI: http://dx.doi.org/10.1111/j.1747-0285.2008.00746.x
		[A] - KARCH CHRISTOPHER P ET AL, "Vaccination with self-adjuvanted protein nanoparticles provides protection against lethal influenza challenge", NANOMEDICINE: NANOTECHNOLOGY, BIOLOGY AND MEDICINE, ELSEVIER, NL, (20160902), vol. 13, no. 1, doi:10.1016/J.NANO.2016.08.030, ISSN 1549-9634, pages 241 - 251, XP029879773 [A] 1-15 * the whole document * DOI: http://dx.doi.org/10.1016/j.nano.2016.08.030
		[A] - YASSINE H M ET AL, "Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection", NATURE MEDICINE, NATURE PUBLISHING GROUP, GB, vol. 21, no. 9, doi:10.1038/NM.3927, ISSN 1546-170X, (20150901), pages 1065 - 1070, (20150824), XP002755796 [A] 1-15 * the whole document * * figure 1 * DOI: http://dx.doi.org/10.1038/nm.3927
	by applicant	EP0201416
		EP1262555
		WO2004071493
		WO2009109428
		WO2014079842
		WO2015104352
		- PANCERA, M. et al., Nature, (20140000), vol. 514, no. 7523, pages 455 - 461
		- GUTHE, S. et al., J Mol Biol, (20040000), vol. 337, no. 4, pages 905 - 915
		- LU, Y. et al., Proc Natl Acad Sci USA, (20140000), vol. 111, no. 1, pages 125 - 130
		- KANEKIYO, M. et al., Nature, (20130000), vol. 499, no. 7456, pages 102 - 106
		- YASSINE, H. M. et al., Nat Med, (20150000), vol. 21, no. 9, pages 1065 - 1070
		- DANIELS, R. et al., Mol Cell, (20030000), vol. 11, no. 1, pages 79 - 90
		- RAMAN S.K. et al., Nanomed, (20060000), vol. 2, no. 2, pages 95 - 102
		- PIMENTEL T. A. et al., Chem Biol Drug Des., (20090000), vol. 73, no. 1, pages 53 - 61
		- INDELICATO, G. et al., Biophys J., (20160000), vol. 110, no. 3, pages 646 - 660
		- KARCH, C. P. et al., Nanomedicine, (20160000), vol. 13, no. 1, pages 241 - 251
		- YOON S.I. et al., Science, (20120000), vol. 335, pages 859 - 864
		- LIGHTFIELD K.L. et al., Nat Immunol., (20080000), vol. 9, pages 1171 - 1178
		- BURKHARD P. et al., Protein Science, (20000000), vol. 9, pages 2294 - 2301
		- FENDER P. et al., Nature Biotechnology, (19970000), vol. 15, pages 52 - 56
		- BURKHARD P. et al., Trends Cell Biol, (20010000), vol. 11, pages 82 - 88
		- GRUBER M., J. Struct. Biol., (20060000), vol. 155, no. 2, pages 140 - 145
		- BOYKEN, S. E. et al., Science, (20160000), vol. 352, no. 6286, pages 680 - 687
		- PODBILEWICZ, B., Annu Rev Cell Dev Biol., (20140000), vol. 30, pages 111 - 139
		- INDELICATO, G. et al., Biophys J, (20160000), vol. 110, no. 3, pages 646 - 660
		- LIU, J. et al., Proc Natl Acad Sci USA, (20040000), vol. 101, no. 46, pages 16156 - 16161
		- WEISSENHORN, W. et al., Nature, (19970000), vol. 387, no. 6631, pages 426 - 430
		- BAI, X. et al., Biochemistry, (20080000), vol. 47, no. 25, pages 6662 - 6670

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p